CELLCEPT 1 g/5 ml, powder for oral suspension bottle, 110 g, parallel import (Abacus Medicine A/S)
Brand page: CellCept (mycophenolate mofetil) — all forms and strengths in France
Active ingredients: Mycophenolate mofetil
Commercialized according to BDPMDispensing in France: Prescription only
Powder for oral suspensionbottle, 110 g, parallel import (Abacus Medicine A/S)orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CELLCEPT 1 g/5 mL, poudre pour suspension buvable
- Pharmaceutical form
- poudre pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon(s) polyéthylène haute densité (PEHD) avec seringue(s) pour administration orale de 110 g (distributeur parallèle : Abacus Medicine A/S).
- Marketing authorisation holder
- ROCHE REGISTRATION (ALLEMAGNE)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Jul 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69594306CIP74950120CIP133400949501205Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MYCOPHÉNOLATE MOFÉTILpoudre | 35 g · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.